Mr. Elad Bibi-Aviv reports

SEEGNAL ACCEPTED INTO INNOVATIVE ACCELERATOR PROGRAM FROM AARP, THE LARGEST U.S. ORGANIZATION SERVING AMERICANS 50 AND OLDER

Seegnal Inc. has been accepted into the AgeTech Collaborative from AARP Accelerator Program as part of its summer 2026 cohort.

AARP is the largest non-profit, non-partisan organization in the United States, dedicated to empowering Americans 50 and older to choose how they live as they age. The acceptance comes as Seegnal accelerates its expansion into the United States, the world's largest health care market.

The milestone builds on a period of growing U.S. commercial momentum for the company. In May, 2026, Seegnal announced its first pilot engagement in the U.S. market, a letter of intent with a U.S.-based long-term care provider. Acceptance into the AgeTech Collaborative is intended to broaden Seegnal's relationships across the U.S. age-tech sector, connecting the company with a network of investors, enterprise partners and testbed sites focused on technology for older adults.

The AgeTech Collaborative from AARP is an innovation ecosystem focused on technology that supports healthy aging. The accelerator is an eight-week program offered at no cost and without any equity requirement, providing participants with strategic guidance, consumer insights and access to the broader AgeTech Collaborative network.

Seegnal's focus aligns closely with the program's mission. Older adults are among the populations most affected by adverse drug events, driven in part by polypharmacy, and Seegnal's clinical decision support platform is designed to address these risks by delivering patient-specific medication intelligence at the point of care.

"This is an exciting step in our U.S. growth strategy," said Elad Bibi-Aviv, chief executive officer of Seegnal. "Being selected for the AgeTech Collaborative from AARP connects us with a leading network in the U.S. age-tech space at a time when we are actively expanding our presence in the American market. Medication safety for older adults is one of health care's most important challenges, and we are proud to advance that mission alongside this community."

About Seegnal Inc.

Seegnal is an innovative health care technology company dedicated to reducing medication-related harm where care begins. The company's software-as-a-service-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing and advance a more personalized standard of patient care. Seegnal's technology is deployed across health care settings and is used by more than 15,000 clinicians in daily practice.

We seek Safe Harbor.